UPDATE 2-Lilly revenue beats as diabetes drug sales rise

* Shares marginally up at $75.05 premarket (Adds details, analysts comments, shares) [Source]

Publication Date: Tuesday, 31 January 2017 at 16:01:45

Origin: reuters.com

Category: rbssHealthcareNews

Topics: shares), comments, analysts, details, (Adds, premarket, marginally, Shares, sales, diabetes, beats, revenue, 2-Lilly, UPDATE

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/mfoWCbi8W4M/eli-lilly-results-idUSL4N1FL22W

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22